CHMP approves Roche’s Zelboraf for melanoma: http://www.bloomberg.com/news/2011-12-16/roche-s-zelboraf-melanoma-drug-wins-backing-of-eu-regulator-1-.html The EU will rubber stamp the decision in 2-3 months.